Loading...
TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
Comparatively less toxic and more tolerated, epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are recommendable for advanced non-small-cell lung cancer (NSCLC) patients with EGFR-sensitive mutations. Some EGFR wild-type patients with specific biomarkers also show a response to...
Na minha lista:
| Udgivet i: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433914/ https://ncbi.nlm.nih.gov/pubmed/30911072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-1519-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|